NO20021898D0 - Farmasöytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa - Google Patents

Farmasöytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa

Info

Publication number
NO20021898D0
NO20021898D0 NO20021898A NO20021898A NO20021898D0 NO 20021898 D0 NO20021898 D0 NO 20021898D0 NO 20021898 A NO20021898 A NO 20021898A NO 20021898 A NO20021898 A NO 20021898A NO 20021898 D0 NO20021898 D0 NO 20021898D0
Authority
NO
Norway
Prior art keywords
mucosa
application
pharmaceutical composition
composition containing
containing ciclesonide
Prior art date
Application number
NO20021898A
Other languages
English (en)
Other versions
NO327444B1 (no
NO20021898L (no
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021898(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of NO20021898D0 publication Critical patent/NO20021898D0/no
Publication of NO20021898L publication Critical patent/NO20021898L/no
Publication of NO327444B1 publication Critical patent/NO327444B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20021898A 1999-10-20 2002-04-22 Farmasøytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa NO327444B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20
PCT/JP2000/007350 WO2001028562A1 (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Publications (3)

Publication Number Publication Date
NO20021898D0 true NO20021898D0 (no) 2002-04-22
NO20021898L NO20021898L (no) 2002-04-22
NO327444B1 NO327444B1 (no) 2009-06-29

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021898A NO327444B1 (no) 1999-10-20 2002-04-22 Farmasøytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa

Country Status (36)

Country Link
US (1) US6767901B1 (no)
EP (1) EP1225902B1 (no)
JP (1) JP4264211B2 (no)
KR (1) KR100722209B1 (no)
CN (2) CN1379674B (no)
AR (1) AR026072A1 (no)
AT (1) ATE285779T1 (no)
AU (1) AU781895B2 (no)
BG (1) BG65818B1 (no)
BR (1) BRPI0014878B8 (no)
CA (1) CA2388322C (no)
CO (1) CO5261494A1 (no)
CZ (1) CZ297779B6 (no)
DE (1) DE60017175T2 (no)
DK (1) DK1225902T3 (no)
EA (1) EA006015B1 (no)
ES (1) ES2234681T3 (no)
HK (2) HK1050858A1 (no)
HR (1) HRP20020346B1 (no)
HU (1) HU228893B1 (no)
IL (2) IL148691A0 (no)
ME (1) ME00567A (no)
MX (1) MXPA02003974A (no)
MY (1) MY136987A (no)
NO (1) NO327444B1 (no)
NZ (1) NZ518298A (no)
PE (1) PE20010712A1 (no)
PL (1) PL199702B1 (no)
PT (1) PT1225902E (no)
RS (1) RS50310B (no)
SI (1) SI1225902T1 (no)
SK (1) SK286196B6 (no)
TR (1) TR200200841T2 (no)
TW (1) TWI225788B (no)
WO (1) WO2001028562A1 (no)
ZA (1) ZA200203077B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
EP3513813A1 (en) * 2002-07-02 2019-07-24 Astrazeneca Ciclesonide-containing sterile aqueous suspension
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
AU2003261225A1 (en) * 2002-07-26 2004-02-16 Fmc Corporation Production of microcrystalline cellulose
SI1545548T1 (sl) * 2002-08-30 2010-11-30 Nycomed Gmbh Uporaba kombinacije ciklezonida in antihistaminikov za zdravljenje alergijskega rinitisa
WO2004052374A1 (en) * 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
WO2005025578A1 (en) * 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
CA2579007A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
WO2009114192A2 (en) * 2008-03-14 2009-09-17 Cephalon, Inc. Enhanced transmucosal composition and dosage form
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
EP1050299A4 (en) 1998-01-22 2007-05-02 Santen Pharmaceutical Co Ltd SUSPENSION COLLYRE OF FLUOROMETHOLONE
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
BG65818B1 (bg) 2010-01-29
CA2388322C (en) 2007-09-18
CO5261494A1 (es) 2003-03-31
DE60017175D1 (de) 2005-02-03
HUP0203339A2 (hu) 2003-02-28
JP2003512329A (ja) 2003-04-02
KR20020059627A (ko) 2002-07-13
NZ518298A (en) 2003-11-28
NO327444B1 (no) 2009-06-29
BRPI0014878B8 (pt) 2021-05-25
EA006015B1 (ru) 2005-08-25
CN1379674A (zh) 2002-11-13
IL148691A0 (en) 2002-09-12
CN1379674B (zh) 2014-10-29
CZ297779B6 (cs) 2007-03-28
RS50310B (sr) 2009-09-08
HRP20020346B1 (en) 2011-06-30
DK1225902T3 (da) 2005-05-02
TR200200841T2 (tr) 2002-07-22
EP1225902B1 (en) 2004-12-29
DE60017175T2 (de) 2005-12-29
ME00567B (me) 2011-12-20
MY136987A (en) 2008-12-31
AU7953100A (en) 2001-04-30
NO20021898L (no) 2002-04-22
EP1225902A1 (en) 2002-07-31
AR026072A1 (es) 2002-12-26
EA200200375A1 (ru) 2002-10-31
PL199702B1 (pl) 2008-10-31
TWI225788B (en) 2005-01-01
HK1149719A1 (en) 2011-10-14
HUP0203339A3 (en) 2004-07-28
BRPI0014878B1 (pt) 2015-08-11
ATE285779T1 (de) 2005-01-15
IL148691A (en) 2006-12-10
HU228893B1 (hu) 2013-06-28
ES2234681T3 (es) 2005-07-01
SK6922002A3 (en) 2002-09-10
BG106512A (bg) 2002-12-29
HK1050858A1 (zh) 2003-07-11
ZA200203077B (en) 2003-02-26
HRP20020346A2 (en) 2004-02-29
CN101869570B (zh) 2012-10-10
BR0014878A (pt) 2002-06-11
MXPA02003974A (es) 2003-09-25
CA2388322A1 (en) 2001-04-26
WO2001028562A1 (en) 2001-04-26
PE20010712A1 (es) 2001-07-12
YU28002A (sh) 2004-11-25
SK286196B6 (sk) 2008-05-06
ME00567A (en) 2011-12-20
CN101869570A (zh) 2010-10-27
PL356191A1 (en) 2004-06-14
SI1225902T1 (en) 2005-06-30
AU781895B2 (en) 2005-06-23
KR100722209B1 (ko) 2007-05-29
CZ20021238A3 (cs) 2002-07-17
JP4264211B2 (ja) 2009-05-13
US6767901B1 (en) 2004-07-27
PT1225902E (pt) 2005-05-31

Similar Documents

Publication Publication Date Title
HK1149719A1 (en) Ciclesonide contained pharmaceutical composition for application to mucosa
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
NO20015175D0 (no) Farmasöytisk sammensetning
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
PT1242087E (pt) Composicoes farmaceuticas
FI991485A0 (fi) Uusi farmaseuttinen koostumus
NO20020464D0 (no) Flerkomponent-farmasöytisk doseringsform
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
HUP0002512A3 (en) Medicinal compositions for application to mucosa
DK1156806T3 (da) Farmaceutisk sammensætning indeholdende protonpumpeinhibitor
EE200200393A (et) Glüburiidi ravimkoostis
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DK1210119T3 (da) Farmaceutiske sammensætninger til oral og topisk administrering
PT1239832E (pt) Composicoes farmaceuticas
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
EE200100281A (et) Analgeetiline ravimkoostis
AR025867A1 (es) Formulacion portasdora farmaceutica
ITTO20020672A0 (it) Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
PT1189600E (pt) Composicoes farmaceuticas liofilizadas contendo grf
ITMI992202A0 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori
ATA171599A (de) Pharmazeutische zusammensetzung zur abdeckung des grundbedarfs an vitaminen
DK200100203U4 (da) Farmaceutisk komposition indeholdende citalopram
DK1165081T3 (da) Fremgangsmåde til fremstilling af tolperisonholdige farmaceutiske præparater til oral indgivelse

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ASTRAZENECA AB, SE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: COVIS PHARMA B.V., CH

CREP Change of representative

Representative=s name: BRYN AARFLOT AS, STORTINGSGATA 8, 0161 OSLO, NORGE

MK1K Patent expired